StoxGlobal Health vs Aster DM Quality Care: share price & financials comparison
NSE: MEDANTA vs ASTERDM · Healthcare · as of 06 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Global Health vs Aster DM Quality Care at a glance
Global Health (MEDANTA) has a market capitalisation of ₹37,281 Cr, against ₹36,950 Cr for Aster DM Quality Care (ASTERDM). Over the past year Aster DM Quality Care has returned +1.9%, compared with +0.9% for Global Health. On valuation, Global Health trades at a lower P/E of 93.7 versus 115.9. Global Health earns a higher return on equity (9.2% vs 7.0%). Global Health comes out ahead on size, profitability, growth and technicals. Aster DM Quality Care comes out ahead on valuation and financial health. Across the scored metrics below, Global Health leads on 10 and Aster DM Quality Care on 6. On StoxGud's 10-point checklist, Global Health scores 6/10 and Aster DM Quality Care scores 5/10.
| Metric | Global Health | Aster DM Quality Care |
|---|---|---|
| Size | ||
| Market cap | ₹37,281 Cr | ₹36,950 Cr |
| Revenue (latest FY) | ₹4,410 Cr | ₹4,643 Cr |
| Net profit (latest FY) | ₹556 Cr | ₹388 Cr |
| Valuation | ||
| P/E | 93.7 | 115.9 |
| P/B | 8.62 | 8.08 |
| Dividend yield | 0.04% | 0.15% |
| Profitability | ||
| Return on equity | 9.2% | 7.0% |
| Net profit margin | 7.9% | 6.5% |
| Operating margin | 22.1% | 19.6% |
| Growth | ||
| Revenue growth (YoY) | +33.6% | +21.6% |
| Net profit growth (YoY) | -100.0% | -81.2% |
| Revenue CAGR (multi-year) | +17.9% | -11.6% |
| Financial health | ||
| Debt to equity | 0.16 | 0.15 |
| Momentum | ||
| 1-month return | +7.2% | +4.8% |
| 1-year return | +0.9% | +1.9% |
| 3-year CAGR | +18.3% | +28.6% |
| 5-year CAGR | — | +30.1% |
| Distance from 52W high | -8.0% | -18.0% |
| Technicals | ||
| RSI (14) | 71 | 64 |
| Price vs 200-day avg | +11.1% | -0.4% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Global Health | Aster DM Quality Care |
|---|---|---|
| Price above 50-day average | ✓ | ✗ |
| Price above 200-day average | ✓ | ✗ |
| 50-day average above 200-day (uptrend) | ✓ | ✓ |
| RSI in healthy 40–70 zone | ✗ | ✓ |
| Positive 1-year return | ✓ | ✓ |
| Return on equity above 15% | ✗ | ✗ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✗ | ✗ |
| P/E below industry median | ✗ | ✗ |
| Score | 6/10 | 5/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Global Health or Aster DM Quality Care?
Global Health has a market cap of ₹37,281 Cr and Aster DM Quality Care has a market cap of ₹36,950 Cr as of 06 Nov 2026.
Which has a lower P/E, Global Health or Aster DM Quality Care?
Global Health has the lower P/E: Global Health trades at 93.7 and Aster DM Quality Care at 115.9.
Which gave better returns in the last year, Global Health or Aster DM Quality Care?
Aster DM Quality Care did better: Global Health returned +0.9% and Aster DM Quality Care returned +1.9% over one year.
Is Global Health or Aster DM Quality Care a better buy?
StoxGud does not give buy or sell recommendations. On our rules-based checklist Global Health scores 6/10 and Aster DM Quality Care scores 5/10; compare valuation, profitability, growth and momentum above and consult a SEBI-registered adviser.